Generic-drug makers to lobby to get products to market faster

10/14/2009 | Roll Call (subscription required)

Now that the Senate Finance Committee has passed its version of the health care reform bill, the genetic-drug industry will begin lobbing lawmakers on provisions that determine how quickly generic versions of biologic drugs can be marketed. Brand-name biologic manufacturers want to hold off generics for 12 years, but generics makers argue the time frame should be reduced to no more than seven years to reduce health care spending. "The current bill is not going to provide needed access to affordable life saving medicines," the president of the Generic Pharmaceutical Association said.

View Full Article in:

Roll Call (subscription required)